Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2007, Article ID 97272, 5 pages
http://dx.doi.org/10.1155/2007/97272
Research Article

Peritoneal Protein Losses and Cytokine Generation in Automated Peritoneal Dialysis with Combined Amino Acids and Glucose Solutions

1Department of Internal Medicine, Erasmus MC, Rotterdam 3015 CE, The Netherlands
2Department of Anaesthesiology, Erasmus MC, Rotterdam 3015 CE, The Netherlands
3Department of Clinical Genetics, Erasmus MC, Rotterdam 3015 CE, The Netherlands

Received 26 September 2007; Accepted 26 November 2007

Copyright © 2007 H. L. Tjiong et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. D. Kopple, M. J. Blumenkrantz, M. R. Jones, J. K. Moran, and J. W. Coburn, “Plasma amino acid levels and amino acid losses during continuous ambulatory peritoneal dialysis,” American Journal of Clinical Nutrition, vol. 36, no. 3, pp. 395–402, 1982. View at Google Scholar
  2. N. Dombros, A. Oren, E. B. Marliss et al., “Plasma amino acid profiles and amino acid losses in patients undergoing CADP,” Peritoneal Dialysis International, vol. 2, no. 1, pp. 27–32, 1982. View at Google Scholar
  3. M. J. Blumenkrant, G. M. Gahl, J. D. Kopple et al., “Protein losses during peritoneal dialysis,” Kidney International, vol. 19, no. 4, pp. 593–602, 1981. View at Publisher · View at Google Scholar
  4. J. T. Dulaney and F. E. Hatch Jr., “Peritoneal dialysis and loss of proteins: a review,” Kidney International, vol. 26, no. 3, pp. 253–262, 1984. View at Publisher · View at Google Scholar
  5. R. P. Popovich, J. W. Moncrief, K. D. Nolph, A. J. Ghods, Z. J. Twardowski, and W. K. Pyle, “Continuous ambulatory peritoneal dialysis,” Annals of Internal Medicine, vol. 88, no. 4, pp. 449–456, 1978. View at Google Scholar
  6. J. Rubin, K. D. Nolph, D. Arfania et al., “Protein losses in continuous ambulatory peritoneal dialysis,” Nephron, vol. 28, no. 5, pp. 218–221, 1981. View at Google Scholar
  7. A. Katirtzoglou, D. G. Oreopoulos, H. Husdan, M. Leung, R. Ogilvie, and N. Dombros, “Reappraisal of protein losses in patients undergoing continuous ambulatory peritoneal dialysis,” Nephron, vol. 26, no. 5, pp. 230–233, 1980. View at Google Scholar
  8. S. Gordon and M. E. Rubini, “Protein losses during peritoneal dialysis,” American Journal of the Medical Sciences, vol. 253, no. 3, pp. 283–292, 1967. View at Google Scholar
  9. R. T. Krediet, F. M. J. Zuyderhoudt, E. W. Boeschoten, and L. Arisz, “Peritoneal permeability to proteins in diabetic and non-diabetic continuous ambulatory peritoneal dialysis patients,” Nephron, vol. 42, no. 2, pp. 133–140, 1986. View at Google Scholar
  10. T. A. Ikizler, J. H. Greene, R. L. Wingard, R. A. Parker, and R. M. Hakim, “Spontaneous dietary protein intake during progression of chronic renal failure,” Journal of the American Society of Nephrology, vol. 6, no. 5, pp. 1386–1391, 1995. View at Google Scholar
  11. H. L. Tjiong, J. W. van den Berg, J. L. Wattimena et al., “Dialysate as food: combined amino acid and glucose dialysate improves protein anabolism in renal failure patients on automated peritoneal dialysis,” Journal of the American Society of Nephrology, vol. 16, no. 5, pp. 1486–1493, 2005. View at Publisher · View at Google Scholar
  12. H. B. Steinhauer, I. Lubrich-Birkner, R. Kluthe, G. Baumann, and P. Schollmeyer, “Effect of amino acid based dialysis solution on peritoneal permeability and prostanoid generation in patients undergoing continuous ambulatory peritoneal dialysis,” American Journal of Nephrology, vol. 12, no. 1-2, pp. 61–67, 1992. View at Google Scholar
  13. J. Plum, A. Fussholler, G. Schoenicke et al., “In vivo and in vitro effects of amino-acid-based and bicarbonate-buffered peritoneal dialysis solutions with regard to peritoneal transport and cytokines/prostanoids dialysate concentrations,” Nephrology Dialysis Transplantation, vol. 12, no. 8, pp. 1652–1660, 1997. View at Publisher · View at Google Scholar
  14. G. A. Young, J. B. Dibble, A. E. Taylor, S. Kendall, and A. M. Brownjohn, “A longitudinal study of the effects of amino acid-based CAPD fluid on amino acid retention and protein losses,” Nephrology Dialysis Transplantation, vol. 4, no. 10, pp. 900–905, 1989. View at Google Scholar
  15. M. Jones, T. Hagen, C. A. Boyle, E. Vonesh et al., “Treatment of malnutrition with 1.1% Amino acid peritoneal dialysis solution: results of a multicenter outpatient study,” American Journal of Kidney Diseases, vol. 32, no. 5, pp. 761–769, 1998. View at Google Scholar
  16. W. M. Westra, J. D. Kopple, R. T. Krediet, M. Appell, and R. Mehrotra, “Dietary protein requirements and dialysate protein losses in chronic peritoneal dialysis patients,” Peritoneal Dialysis International, vol. 27, no. 2, pp. 192–195, 2007. View at Google Scholar
  17. K. D. Nolph, Z. J. Twardowski, R. P. Popovich, and J. Rubin, “Equilibration of peritoneal dialysis solutions during long-dwell exchanges,” Journal of Laboratory and Clinical Medicine, vol. 93, no. 2, pp. 246–256, 1979. View at Google Scholar
  18. P. Kathuria, H. L. Moore, R. Khanna, Z. J. Twardowski, S. Goel, and K. D. Nolph, “Effect of dialysis modality and membrane transport characteristics on dialysate protein losses of patients on peritoneal dialysis,” Peritoneal Dialysis International, vol. 17, no. 5, pp. 449–454, 1997. View at Google Scholar
  19. H. L. Tjiong, T. Rietveld, J. L. Wattimena et al., “Peritoneal dialysis with solutions containing amino acids plus glucose promotes protein synthesis during oral feeding,” Clinical Journal of the American Society of Nephrology, vol. 2, no. 1, pp. 74–80, 2007. View at Publisher · View at Google Scholar
  20. C. E. Douma, D. R. de Waart, D. G. Struijk, and R. T. Krediet, “Effect of amino acid based dialysate on peritoneal blood flow and permeability in stable CAPD patients: a potential role for nitric oxide?” Clinical Nephrology, vol. 45, no. 5, pp. 295–302, 1996. View at Google Scholar
  21. A. Olszowska, J. Waniewski, A. Werynski, B. Anderstam, B. Lindholm, and Z. Wankowicz, “Peritoneal transport in peritoneal dialysis patients using glucose-based and amino acid-based solutions,” Peritoneal Dialysis International, vol. 27, no. 5, pp. 544–553, 2007. View at Google Scholar
  22. D. Zemel, R. J. M. ten Berge, D. G. Struijk, E. Bloemena, G. C. M. Koomen, and R. T. Krediet, “Interleukin-6 in CAPD patients without peritonitis: relationship to the intrinsic permeability of the peritoneal membrane,” Clinical Nephrology, vol. 37, no. 2, pp. 97–103, 1992. View at Google Scholar
  23. M. Goldman, P. Vandenabeele, J. Moulart et al., “Intraperitoneal secretion of interleukin-6 during continuous ambulatory peritoneal dialysis,” Nephron, vol. 56, no. 3, pp. 277–280, 1990. View at Google Scholar
  24. D. Zemel, A. L.T. Imholz, D. R. de Waart, C. Dinkla, D. G. Struijk, and R. T. Krediet, “Appearance of tumor necrosis factor-α and soluble TNF-receptors I and II in peritoneal effluent of CAPD,” Kidney International, vol. 46, no. 5, pp. 1422–1430, 1994. View at Publisher · View at Google Scholar
  25. T. A. Martikainen, A.-M. Teppo, C. Grönhagen-Riska, and A. V. Ekstrand, “Glucose-free dialysis solutions: inductors of inflammation or preservers of peritoneal membrane?” Peritoneal Dialysis International, vol. 25, no. 5, pp. 453–460, 2005. View at Google Scholar
  26. N. Topley, A. Jorres, W. Luttmann et al., “Human peritoneal mesothelial cells synthesize interleukin-6: induction by IL-1ß and TNFa,” Kidney International, vol. 43, no. 1, pp. 226–233, 1993. View at Publisher · View at Google Scholar
  27. M. W. J. A. Fieren, G. J. C. M. van den Bemd, and I. L. Bonta, “Endotoxin-stimulated peritoneal macrophages obtained from continuous ambulatory peritoneal dialysis patients show an increased capacity to release interleukin-1β in vitro during infectious peritonitis,” European Journal of Clinical Investigation, vol. 20, no. 4, pp. 453–457, 1990. View at Google Scholar
  28. W. M. Pruimboom, D. J. Bac, A. P. M. van Dijk et al., “Levels of soluble intercellular adhesion molecule 1, eicosanoids and cytokines in ascites of patients with liver cirrhosis, peritoneal cancer and spontaneous bacterial peritonitis,” International Journal of Immunopharmacology, vol. 17, no. 5, pp. 375–384, 1995. View at Publisher · View at Google Scholar